SB218078

Modify Date: 2025-08-20 19:50:28

SB218078 Structure
SB218078 structure
Common Name SB218078
CAS Number 135897-06-2 Molecular Weight 393.39400
Density N/A Boiling Point N/A
Molecular Formula C24H15N3O3 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of SB218078


SB-218078 is a potent, selective and cell-permeable checkpoint kinase 1 (Chk1) inhibitor that inhibits Chk1 phosphorylation of cdc25C with an IC50 of 15 nM. SB-218078 is less potently inhibits Cdc2 (IC50 of 250 nM) and PKC (IC50 of 1000 nM). SB-218078 causes apoptosis by DNA damage and cell cycle arrest[1][2][3].

 Names

Name sb 218078
Synonym More Synonyms

 SB218078 Biological Activity

Description SB-218078 is a potent, selective and cell-permeable checkpoint kinase 1 (Chk1) inhibitor that inhibits Chk1 phosphorylation of cdc25C with an IC50 of 15 nM. SB-218078 is less potently inhibits Cdc2 (IC50 of 250 nM) and PKC (IC50 of 1000 nM). SB-218078 causes apoptosis by DNA damage and cell cycle arrest[1][2][3].
Related Catalog
Target

Chk1:15 nM (IC50)

Cdc2:250 nM (IC50)

PKC:1000 nM (IC50)

In Vitro SB-218078 (2.5-5 μM; 18 hours; HeLa cells) treatment abrogates G2 cell cycle arrest caused by either γ-irradiation or a topoisomerase I Topotecan inhibition[1]. SB-218078 (500-625 μM; 96 hours; HeLa and HT-29 cells) treatment significantly increases the cytotoxicity of DNA damage [1]. Cell Cycle Analysis[1] Cell Line: HeLa cells Concentration: 2.5 μM, 5 μM Incubation Time: 18 hours Result: Abrogated G2 cell cycle arrest caused by γ-irradiation and topoisomerase I inhibition. Cell Cytotoxicity Assay[1] Cell Line: HeLa and HT-29 cells Concentration: 500 nM, 625 nM Incubation Time: 96 hours Result: Enhanced cytotoxicity of DNA damage.
In Vivo SB-218078 (5 mg/kg; intraperitoneal injection; for 16 hours; C57/Bl6 mice) treatment could promote a strong increase of γ-H2AX and apoptosis throughout the lymphoma, while having no effect on a healthy spleen in Myc-induced lymphomas mouse model[2]. Animal Model: C57/Bl6 mice injected with ARF-/- lymphomas[2] Dosage: 5 mg/kg Administration: Intraperitoneal injection; for 16 hours Result: Promoted a strong increase of γ-H2AX and apoptosis throughout the lymphoma.
References

[1]. Jackson JR, et al. An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage. Cancer Res. 2000 Feb 1;60(3):566-72.

[2]. Murga M, et al. Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors. Nat Struct Mol Biol. 2011 Nov 27;18(12):1331-1335.

[3]. Preet R, et al. Chk1 inhibitor synergizes quinacrine mediated apoptosis in breast cancer cells by compromising the base excision repair cascade. Biochem Pharmacol. 2016 Apr 1;105:23-33.

 Chemical & Physical Properties

Molecular Formula C24H15N3O3
Molecular Weight 393.39400
Exact Mass 393.11100
PSA 69.02000
LogP 4.36310
Index of Refraction 1.97

 Synonyms

hms3229o08
SB218078
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.